PMC:7402624 / 50578-50900 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T430","span":{"begin":244,"end":249},"obj":"Body_part"}],"attributes":[{"id":"A430","pred":"fma_id","subj":"T430","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":" or 2 captured mainly signals of change or differences in individual immune features in COVID-19 disease compared to HD and RD. UMAP Component 1 captured an immunotype (Immunotype 1) that was characterized by effector or highly activated CD4 T cells, low cTfh, some CD8 TEMRA-like activation, possibly hyperactivated CD8 T"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1677","span":{"begin":238,"end":241},"obj":"Gene"},{"id":"1678","span":{"begin":266,"end":269},"obj":"Gene"},{"id":"1679","span":{"begin":317,"end":320},"obj":"Gene"},{"id":"1691","span":{"begin":88,"end":96},"obj":"Disease"},{"id":"1692","span":{"begin":117,"end":119},"obj":"Disease"}],"attributes":[{"id":"A1677","pred":"tao:has_database_id","subj":"1677","obj":"Gene:920"},{"id":"A1678","pred":"tao:has_database_id","subj":"1678","obj":"Gene:925"},{"id":"A1679","pred":"tao:has_database_id","subj":"1679","obj":"Gene:925"},{"id":"A1691","pred":"tao:has_database_id","subj":"1691","obj":"MESH:C000657245"},{"id":"A1692","pred":"tao:has_database_id","subj":"1692","obj":"MESH:D006816"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" or 2 captured mainly signals of change or differences in individual immune features in COVID-19 disease compared to HD and RD. UMAP Component 1 captured an immunotype (Immunotype 1) that was characterized by effector or highly activated CD4 T cells, low cTfh, some CD8 TEMRA-like activation, possibly hyperactivated CD8 T"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T345","span":{"begin":88,"end":96},"obj":"Disease"},{"id":"T346","span":{"begin":117,"end":119},"obj":"Disease"},{"id":"T347","span":{"begin":124,"end":126},"obj":"Disease"}],"attributes":[{"id":"A345","pred":"mondo_id","subj":"T345","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A346","pred":"mondo_id","subj":"T346","obj":"http://purl.obolibrary.org/obo/MONDO_0007739"},{"id":"A347","pred":"mondo_id","subj":"T347","obj":"http://purl.obolibrary.org/obo/MONDO_0009973"}],"text":" or 2 captured mainly signals of change or differences in individual immune features in COVID-19 disease compared to HD and RD. UMAP Component 1 captured an immunotype (Immunotype 1) that was characterized by effector or highly activated CD4 T cells, low cTfh, some CD8 TEMRA-like activation, possibly hyperactivated CD8 T"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T782","span":{"begin":22,"end":29},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T783","span":{"begin":124,"end":126},"obj":"http://purl.obolibrary.org/obo/CLO_0008770"},{"id":"T784","span":{"begin":228,"end":237},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T785","span":{"begin":238,"end":241},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T786","span":{"begin":242,"end":249},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T787","span":{"begin":266,"end":269},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T788","span":{"begin":281,"end":291},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T789","span":{"begin":317,"end":320},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"}],"text":" or 2 captured mainly signals of change or differences in individual immune features in COVID-19 disease compared to HD and RD. UMAP Component 1 captured an immunotype (Immunotype 1) that was characterized by effector or highly activated CD4 T cells, low cTfh, some CD8 TEMRA-like activation, possibly hyperactivated CD8 T"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T67025","span":{"begin":117,"end":119},"obj":"Chemical"},{"id":"T78964","span":{"begin":124,"end":126},"obj":"Chemical"},{"id":"T6","span":{"begin":209,"end":217},"obj":"Chemical"}],"attributes":[{"id":"A796","pred":"chebi_id","subj":"T67025","obj":"http://purl.obolibrary.org/obo/CHEBI_73925"},{"id":"A44371","pred":"chebi_id","subj":"T78964","obj":"http://purl.obolibrary.org/obo/CHEBI_73812"},{"id":"A23826","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_35224"}],"text":" or 2 captured mainly signals of change or differences in individual immune features in COVID-19 disease compared to HD and RD. UMAP Component 1 captured an immunotype (Immunotype 1) that was characterized by effector or highly activated CD4 T cells, low cTfh, some CD8 TEMRA-like activation, possibly hyperactivated CD8 T"}